Reproductive Medicine Associates of Michigan — widely known as RMA of Michigan — has been a cornerstone of fertility care in southeastern Michigan since its founding in 2006. Situated at 130 Town Center Drive in Troy, Oakland County, the clinic sits at the heart of one of metro Detroit's most accessible suburban corridors, drawing patients from Auburn Hills, Rochester Hills, Bloomfield Township, Macomb County, and the greater Detroit metro area. Over nearly two decades of operation, the practice has helped bring more than 5,000 babies into the world, earning a strong reputation reflected in its 4.5-star Google rating from more than 269 patient reviews. For families across southeastern Michigan searching for a board-certified reproductive endocrinology team with a proven track record, RMA of Michigan remains one of the region's most trusted destinations. Explore our full guide to fertility clinics in Michigan to compare your options.
Physicians and Clinical Team
RMA of Michigan is led by four board-certified reproductive endocrinologists and infertility (REI) specialists, each with fellowship training from nationally recognized programs.
Dr. Bradley T. Miller, MD, FACOG — Co-founder and Medical Director, Dr. Miller earned his medical degree from Wayne State University School of Medicine and completed his REI fellowship at the National Institutes of Health (NIH). He is board certified by the American Board of Obstetrics and Gynecology (ABOG) with subspecialty certification in Reproductive Endocrinology and Infertility, and is a Fellow of the American College of Obstetricians and Gynecologists (FACOG). Dr. Miller is an active member of the Society for Assisted Reproductive Technology (SART), the American Society for Reproductive Medicine (ASRM), and the Society of Reproductive Endocrinology and Infertility (SREI).
Dr. Lynda J. Wolf, MD, FACOG — Co-founder and Practice Director, Dr. Wolf received her medical degree from the University of Minnesota and completed her residency in Obstetrics and Gynecology at the University of Michigan. She trained in her REI fellowship at the University of North Carolina at Chapel Hill, where she conducted research on endometrial surface protein expression in Dr. Bruce Lessey's laboratory. Prior to co-founding RMA of Michigan, Dr. Wolf established the Assisted Reproductive Technology program at the Medical College of Ohio, building it into one of the most successful ART programs in the region. She holds board certification from ABOG with REI subspecialty certification.
Dr. Jenny S. George, MD — Dr. George earned her Bachelor of Science degree from the University of Michigan, graduating summa cum laude, before completing medical school and an REI fellowship at Harvard Medical School's Brigham and Women's Hospital in Boston. She is board certified in Reproductive Endocrinology and Infertility and is a member of ASRM and SART. Her clinical interests include recurrent pregnancy loss and preimplantation genetic testing.
Dr. Annette Lee, MD — With more than 27 years of experience in reproductive endocrinology, Dr. Lee earned her medical degree from MCP Hahnemann School of Medicine (now Drexel University College of Medicine) and completed her residency at Winthrop University Hospital (now NYU Langone). She trained in an REI fellowship at Oregon Health Sciences University in Portland, Oregon. Dr. Lee specializes in IVF, IUI, fertility preservation, and third-party reproduction.
Dr. Karen C. Wheeler, MD — Dr. Wheeler joined RMA of Michigan in 2019 following her REI fellowship training in Reproductive Medicine and Infertility at Wayne State University / Detroit Medical Center. She also holds a faculty appointment at Oakland University William Beaumont School of Medicine in Rochester, Michigan, where she teaches obstetrics, gynecology, and infertility to residents. She was recognized as a Detroit "Top Doc" by peer physicians in 2020 and 2021.
The laboratory is directed by Joy M. Peterson, BS, TS, ELD, whose credentials span technical supervision and embryology laboratory direction.
Services and Treatments
RMA of Michigan offers a comprehensive menu of reproductive medicine services for individuals and couples at every stage of the fertility journey:
- In Vitro Fertilization (IVF) — including fresh and frozen embryo transfer cycles
- Intrauterine Insemination (IUI) with and without ovarian stimulation
- Egg Freezing (Oocyte Cryopreservation) for elective fertility preservation and medical indications
- Embryo Cryopreservation and Banking
- Preimplantation Genetic Testing (PGT-A and PGT-M) for chromosomal screening and single-gene disorders
- Donor Egg IVF using both fresh and frozen (vitrified) donor oocytes
- Donor Embryo transfer for recipients unable to use their own gametes
- Gestational Carrier / Surrogacy coordination and medical management
- Reciprocal IVF for same-sex female couples
- LGBTQ+ Family Building services including sperm donation, egg donation, and gestational carrier pathways
- Male Factor Evaluation including semen analysis, sperm DNA fragmentation testing, and urologic referral coordination
- Ovarian Tissue Cryopreservation for patients facing gonadotoxic cancer treatment
- Recurrent Pregnancy Loss evaluation and management
- Fertility Treatment for HIV-Positive Patients
- Mental Health Services integrated into fertility care
- Fertility Consultations and Diagnostic Workup including hormonal panels, antral follicle counts, and hysterosalpingography (HSG)
The clinic also serves patients in Ohio, offering IVF care for those in the Toledo region and northwestern Ohio who find Troy more accessible than local alternatives.
Laboratory and Success Rates
The on-site embryology and andrology laboratory at RMA of Michigan operates under SART-verified accreditation, a distinction that confirms the lab meets rigorous quality standards for reproductive tissue handling, cryopreservation, and outcomes reporting. The laboratory supports the full range of ART procedures, including intracytoplasmic sperm injection (ICSI), extended blastocyst culture, vitrification, and comprehensive chromosomal screening via next-generation sequencing.
According to the most recent publicly available data reported to SART (2023 cycle outcomes), RMA of Michigan performed 1,245 total cycles that year. Cumulative live birth rates from all embryo transfers using the patient's own eggs reached 53.1% for patients under 35, 36.8% for ages 35–37, and 24.6% for the 38–40 age group. The clinic's elective single embryo transfer (eSET) rate exceeded 90% for patients under 35, reflecting a strong commitment to singleton pregnancies — the clinic's own historical data shows that more than 91% of deliveries in the under-35 cohort were singletons.
For frozen donor egg cycles, the cumulative live birth rate was 40.0% per start, with thawed embryo transfers from donated embryos achieving a 50.0% live birth rate. The clinic reported 61 oocyte banking (egg freezing) cycles and 8 embryo banking cycles for preservation purposes in 2023.
You can review the clinic's complete outcomes on the SART clinic summary report and on the CDC ART Fertility Clinic Success Rates Report, which provides independently validated national data for all SART-member programs.
Patient Experience
RMA of Michigan's 4.5-star rating is rooted in qualities patients consistently highlight: same-day results turnaround for lab work, clear and direct communication from physicians, flexible scheduling that accommodates working patients (including early-morning weekend monitoring appointments as early as 6:00 AM), and a staff culture that balances clinical professionalism with genuine emotional attentiveness. Reviewers frequently mention feeling like a known patient rather than a number — an experience that can be harder to find at larger multi-location fertility networks.
The clinic pairs every new patient with a dedicated financial counselor at intake, which patients find reduces billing anxiety and clarifies out-of-pocket expectations before treatment begins. The Troy location is easily accessible from I-75, M-59, and Crooks Road, with ample on-site parking at Town Center — a practical advantage for patients making frequent early-morning monitoring visits during stimulation cycles.
RMA of Michigan joined the Innovation Fertility network, which extends access to centralized clinical research, shared laboratory protocols, and a broader referral ecosystem while preserving the practice's independent, community-oriented character.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Michigan does not have a state mandate requiring health insurers to cover infertility treatment, which means coverage varies considerably depending on your employer plan and insurer. RMA of Michigan participates with several major insurance carriers — including Anthem Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare — and many plans cover diagnostic testing, monitoring, medications, and office visits even when they do not cover IVF itself. Every new patient works with a dedicated financial counselor to verify benefits and identify what, if anything, their plan will cover.
For the portion of care not covered by insurance, the clinic offers access to financing options including fertility loans and multi-cycle IVF discount packages, with third-party lending available up to $50,000 through fertility-focused lenders. Patients seeking additional grant resources can explore nonprofit organizations such as the Baby Quest Foundation and the Cade Foundation, which offer competitive grants to fertility patients facing financial barriers.
For a broader discussion of IVF treatment costs and financing strategies, our national guide covers what to expect across the full cycle of care.
Frequently Asked Questions
Does RMA of Michigan treat same-sex couples and single parents? Yes. The clinic has dedicated LGBTQ+ family-building pathways. Same-sex female couples can pursue reciprocal IVF (where one partner provides eggs and the other carries the pregnancy), conventional IVF with donor sperm, or IUI. Same-sex male couples and single fathers are supported through egg donation and gestational carrier programs. Single women can use donor sperm for IUI or IVF. The clinical team has extensive experience coordinating third-party reproduction logistics.
What is the first step to becoming a patient at RMA of Michigan? New patients typically begin with a one-hour consultation with one of the clinic's reproductive endocrinologists, which includes a review of medical history, an initial fertility workup (hormone panel, antral follicle count ultrasound, and, if applicable, semen analysis), and a personalized treatment plan discussion. Appointments can be scheduled by calling (248) 619-3100 or through the clinic's website.
Does RMA of Michigan perform preimplantation genetic testing? Yes. The clinic offers both PGT-A (preimplantation genetic testing for aneuploidies, formerly called PGS) and PGT-M (preimplantation genetic testing for monogenic/single-gene disorders). PGT is typically performed on blastocyst-stage embryos before transfer and can significantly reduce miscarriage risk and increase the likelihood of a viable pregnancy, particularly for patients with recurrent pregnancy loss or known genetic conditions.
How does RMA of Michigan compare to other Michigan fertility clinics? RMA of Michigan distinguishes itself through a combination of physician continuity (patients generally see the same doctor throughout treatment), a high eSET rate reflecting modern embryo transfer standards, a SART-accredited on-site laboratory, and fellowship-trained physicians whose subspecialty credentials exceed what is common in general OB/GYN-based fertility practices. The clinic's 2023 SART data places its live birth rates competitively within the state. Our guide to fertility clinics in Michigan provides a broader state-level comparison.